Hikma Pharmaceuticals PLC Website Screenshot

Hikma Pharmaceuticals PLC Company Intro

Hikma Pharmaceuticals PLC develops, manufactures, and markets a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment develops, manufactures, and sells generic injectable products primarily for use in hospitals. The Generics segment develops and manufactures oral and other non-injectable generic products for the retail market. The Branded segment develops, manufactures, markets, and sells branded generics and in-licensed products to retail and hospital markets. The company offers its products in various therapeutic areas, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, and respiratory. It operates in the United Kingdom, the United States, the Middle East, North Africa, Europe, and internationally. The company was founded in 1978 and is based in London, the United Kingdom.



Hikma Pharmaceuticals PLC Headquaters

1 New Burlington Place
London,W1S 2HR
United Kingdom

Hikma Pharmaceuticals PLC Share price

14 Sep 2022 11:06 GMT


3.5 (0.28 %)

Hikma Pharmaceuticals PLC Market cap

$2.896 B



Hikma Pharmaceuticals PLC # 10

Drug Manufacturers—Specialty & Generic

Latest Hikma Pharmaceuticals PLC News

News 05 Dec 2022

Specialty Injectable Market Top Impacting Factors to Growth of ...

KGaA, Endo International Plc., AstraZeneca, Hikma Pharmaceuticals PLC, ... Sagent Pharmaceuticals Inc., Cipla Limited, Sun Pharmaceutical Industries Limited...

News 05 Dec 2022

Hikma Pharmaceuticals Plc -6.3% potential downside ...

Hikma Pharmaceuticals Plc is a pharmaceutical company. The Company is focused on developing, manufacturing, marketing and selling of a broad range of generic,...

News 05 Dec 2022

Ovarian Cancer Market Research Report 2022, Global ...

Ovarian Cancer Market Research Report 2022, Global ...

WMC Market Score

WMC Market to Revenue Score

Hikma Pharmaceuticals PLC Market Financials

Revenue, Expenses, Profit

Company Currency Revenue Expense Profit Market Cap WMC Sector Score
Hikma Pharmaceuticals PLC USD $2,341,000 $641,000 $431,000 $28,960B 10
Teva Pharmaceutical Industries Limited USD $16,283,000 $4,659,000 $-3,982,000 $99,380B 1
Bausch Health Companies Inc. USD $8,042,000 $4,348,001 $-1,018,000 $26,650B 2
Zoetis Inc. USD $7,012,000 $2,380,000 $1,774,000 $761,690B 3
Perrigo Company plc USD $4,990,000 $1,357,500 $-230,900 $52,610B 4

Market Analytics

Company Search vs Top 4 Industry Competitors

Total Hikma Pharmaceuticals PLC Social Followers vs Top 4 Industry Competitors

Hikma Pharmaceuticals PLC Post vs Top 4 Industry Competitors

Hikma Pharmaceuticals PLC Digital Footprint By Size vs Top 4 Industry Competitors

Hikma Pharmaceuticals PLC Digital Footprint By Change Rate vs Top 4 Industry Competitors

Hikma Pharmaceuticals PLC WMC Market Score Calculations

Details Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Hikma Pharmaceuticals PLC 14.38 0 0 17 0 0 6.14
Teva Pharmaceutical Industries Limited 100 3.55 2.31 59 0 0 23.57
Bausch Health Companies Inc. 49.39 1.02 47.07 100 0 0 53.97
Zoetis Inc. 43.06 100 100 74 0 0 100
Perrigo Company plc 30.65 4.61 3.01 83 0 0 32.94

Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields

You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb